The hostile bid from Roche to take over Illumina spills over to more names (previous: PACB,...
The hostile bid from Roche to take over Illumina spills over to more names (previous: PACB, GNOM, LIFE) on M&A speculation - as Sequenom (SQNM +2.2%), Qiagen (QGEN +1.5%), and Luminex (LMNX +1.1%) all catch bids in early trading.
From other sites
at CNBC.com (Dec 3, 2014)
at CNBC.com (Jan 14, 2014)
at CNBC.com (Mar 15, 2013)
at CNBC.com (Apr 25, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs